Medulloblastoma stem cell programs: Molecular roadmaps of disease progression

Area of Science:

• Neuroscience
• Oncology
• Developmental Biology

Background:

• Medulloblastoma (MB) is a highly heterogeneous pediatric brain cancer.
• Extensive molecular profiling has revealed hijacked neurodevelopmental programs in MB.
• Current treatments struggle to eradicate the stem and progenitor cells driving MB.

Purpose of the Study:

• To summarize current knowledge on the developmental origins of MB.
• To highlight unmet needs in MB research, including tumor modeling and understanding metastatic cell drivers.
• To emphasize the importance of validating MB stem/progenitor cell signatures.

Main Methods:

• Perspective review of existing sequencing and bioinformatics data.
• Analysis of developmental origins and oncogenic hijacking in MB.
• Identification of knowledge gaps in MB modeling and cell fate regulation.

Main Results:

• MB arises from hijacked primitive neurodevelopmental programs.
• Putative stem and early progenitor cells driving MB remain untargeted.
• Gaps exist in human model fidelity, understanding of metastatic cell mechanisms, and post-transcriptional regulation.

Conclusions:

• Effective targeting of MB requires better human models that recapitulate oncogenic events.
• Further research is needed to understand cell fate decisions in primary and metastatic MB.
• Comprehensive validation of MB stem/progenitor cell signatures is crucial for therapeutic development.